PBM audit systems check the days supply field on every claim, and a days supply that does not match the quantity dispensed and the prescriber's directions is among the most common findings in a PBM audit. The error often starts as a rounding shortcut on a fixed quantity product, an insulin pen, an inhaler, or a compounded ointment, using a rule of thumb instead of the product's labeled conversion factor. Once that days supply and quantity mismatch lands on a paid claim, it can trigger a recoupment demand reaching back across the pharmacy's entire audit lookback period.
How a Days Supply Error Becomes a Recoupment Finding
NCPDP's Telecommunication Standard reserves a dedicated Days Supply field on every claim, field 405-D5, accepting a value of 0 to 999, and PBMs use it for refill too soon edits, plan quantity limits, and drug utilization review checks before a desk audit or an on-site audit ever opens. PAAS National, a pharmacy audit assistance organization, reports that overbilled quantities and incorrect days' supply entries account for a sizable share of the chargebacks pharmacies see on audit. A days supply that misstates the product's labeled conversion factor can misstate the quantity billed on the same claim and trigger a refill too soon rejection on the next fill.
Insulin Pens and Vials Follow Different Conversion Math
A standard insulin vial is labeled at 100 units per milliliter, and a 10 milliliter vial supplies 1,000 total units, so days supply equals 1,000 divided by the units used each day. Insulin pens are dispensed by the box, and the total units across the box, not the units in a single pen, is the number that belongs in the calculation. Provider manuals do not always accept that arithmetic without adjustment: Montana Healthcare Programs caps an insulin days supply override at 100 days and limits it to the smallest available package size, a payer specific rule the unit math alone will not surface. PBMs, including OptumRx, apply their own payer specific insulin days supply rules on top of that underlying math.
Inhalers, Drops, and Topicals Share a Method But Not a Conversion Factor
The math for every fixed quantity product is the same, total quantity divided by amount used per day, but the conversion factor changes by category. An inhaler's days supply comes from the labeled actuations in the canister divided by the prescribed actuations per day, a figure printed on the canister rather than the prescription. Ophthalmic and otic drops require a drops per milliliter conversion that is not standardized industry wide: 20 drops per milliliter is a common estimate, but some payers apply 15 or 12 instead, skewing the days supply on every affected claim. Topical creams carry no fixed convention at all, and pharmacies commonly translate an apply to the affected area direction into a gram based estimate tied to the treated area's size.
Changing a Rejected Claim's Quantity or Days Supply Creates a Separate Audit Risk
A days supply or quantity a PBM's system rejects at the point of sale is a common trigger for pharmacies to adjust the numbers rather than obtain a prior authorization, and that shortcut creates a second, independent audit problem. Attorneys at Frier Levitt represented a pharmacy where a PBM alleged it changed a claim's quantity and days supply to bypass a rejection instead of securing the required prior authorization. The claim survived audit only because the pharmacy showed the prescriber had authorized a proportional change to both fields. Absent that authorization, adjusting either field to get a rejected claim paid is itself a recoupable finding, layered on top of any overbilled quantity exposure from an invoice reconciliation review.
A single days supply error rarely stays a single finding; PBMs extrapolate it across the full audit sample.
Why Early Legal Counsel Is Critical
It is critical that pharmacies retain experienced healthcare defense counsel as soon as a PBM opens a days supply audit, rather than waiting for the recoupment letter. Early legal intervention shapes what the pharmacy submits in response to the initial document request, helps distinguish a documented, prescriber authorized adjustment from an unauthorized one, and preserves the conversion factor and prescriber documentation the pharmacy will need if the finding proceeds to an audit appeal. Delaying counsel until after a PBM has extrapolated an error across the audit sample narrows the options available, and can expose the pharmacy to network termination on top of the recoupment.
How Health Law Alliance Can Help
Health Law Alliance represents pharmacies through PBM audits built on days supply and quantity discrepancies, including insulin, inhaler, and topical claims, as part of the firm's PBM audit defense practice. If your pharmacy is facing a days supply audit discrepancy and needs its conversion factor documentation and prescriber authorizations organized into a record the PBM will credit, contact us for a free, confidential consultation.
